IRTC

iRhythm Technologies Inc

Healthcare


Presented:10/13/2022
Price:$118.94
Cap:$3.57B
Current Price:$60.13
Cap:$1.88B

Presented

Date10/13/2022
Price$118.94
Market Cap$3.57B
Ent Value$3.15B
P/E RatioN/A
Book Value$8.17
Div Yield0%
Shares O/S30.03M
Ave Daily Vol363,578
Short Int5.23%

Current

Price$60.13
Market Cap$1.88B
iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers Zio XT, is a wearable patch-based biosensor, which continuously records and stores ECG data from every patient heartbeat for up to 14 consecutive days, and Zio AT, which provides ECG data but also provides physicians with actionable notifications during the wear period. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Publicly traded companies mentioned herein: Abbott Laboratories (ABT), Boston Scientific Corp (BSX), Dexcom Inc (DXCM), iRhythm Technologies Inc (IRTC), Koninklijke Philips NV (PHIA NA)

Highlights

The presenter is long shares of iRhythm Technologies Inc (IRTC), looking for several positive catalysts coming; a beat on Q3 expectations, a constructive CMS ruling, and mSToPS data that could show a potentially significant silent AFib detection opportunity. As these dynamics start to play out in November, he sees upside to the current $120 share price.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.